Search
Close this search box.

Meyrick succeeding CMO Harris at radiopharma ITM

ARTICLE | Management Tracks

Plus: ALX hires Dillon and updates from Obsidian, YS and more

By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst  

May 9, 2024 12:59 AM UTC

ITM Isotope Technologies Munich SE hired Danielle Meyrick to succeed CMO Philip Harris, who is retiring. Meyrick was CSO, research and insights at GenesisCare Inc. Temasek led a €255 million ($272.6 million) equity investment in the radiopharmaceuticals company last June. 

CD47 company  ALX Oncology Holdings Inc. (NASDAQ:ALXO) hired Allison Dillon as CBO. Dillon was SVP, commercial and portfolio strategy at Calithera Biosciences Inc. …